An Updated Framework for SARS-CoV-2 Variants Reflects the Unpredictability of Viral Evolution

Viana R, Moyo S, Amoako D, Tegally H, Scheepers C, Althaus C . Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022; 603(7902):679-686. PMC: 8942855. DOI: 10.1038/s41586-022-04411-y. View

Mykytyn A, Rissmann M, Kok A, Rosu M, Schipper D, Breugem T . Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct. Sci Immunol. 2022; 7(75):eabq4450. PMC: 9273038. DOI: 10.1126/sciimmunol.abq4450. View

Hui K, Ho J, Cheung M, Ng K, Ching R, Lai K . SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022; 603(7902):715-720. DOI: 10.1038/s41586-022-04479-6. View

Altarawneh H, Chemaitelly H, Hasan M, Ayoub H, Qassim S, Almukdad S . Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. N Engl J Med. 2022; 386(13):1288-1290. PMC: 8849180. DOI: 10.1056/NEJMc2200133. View

Willett B, Grove J, MacLean O, Wilkie C, De Lorenzo G, Furnon W . SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022; 7(8):1161-1179. PMC: 9352574. DOI: 10.1038/s41564-022-01143-7. View

Subissi L, von Gottberg A, Thukral L, Worp N, Oude Munnink B, Rathore S . An early warning system for emerging SARS-CoV-2 variants. Nat Med. 2022; 28(6):1110-1115. PMC: 11346314. DOI: 10.1038/s41591-022-01836-w. View

Grant R, Sacks J, Abraham P, Chunsuttiwat S, Cohen C, Figueroa J . When to update COVID-19 vaccine composition. Nat Med. 2023; 29(4):776-780. DOI: 10.1038/s41591-023-02220-y. View

Feikin D, Higdon M, Abu-Raddad L, Andrews N, Araos R, Goldberg Y . Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022; 399(10328):924-944. PMC: 8863502. DOI: 10.1016/S0140-6736(22)00152-0. View

Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C . Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023; 23(5):556-567. PMC: 10014083. DOI: 10.1016/S1473-3099(22)00801-5. View

10.

Yue C, Song W, Wang L, Jian F, Chen X, Gao F . ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5. Lancet Infect Dis. 2023; 23(3):278-280. PMC: 9897732. DOI: 10.1016/S1473-3099(23)00010-5. View

11.

Wang Q, Iketani S, Li Z, Liu L, Guo Y, Huang Y . Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2022; 186(2):279-286.e8. PMC: 9747694. DOI: 10.1016/j.cell.2022.12.018. View

12.

Pickering B, Lung O, Maguire F, Kruczkiewicz P, Kotwa J, Buchanan T . Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission. Nat Microbiol. 2022; 7(12):2011-2024. PMC: 9712111. DOI: 10.1038/s41564-022-01268-9. View

13.

Ozer E, Simons L, Adewumi O, Fowotade A, Omoruyi E, Adeniji J . Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria. Nat Commun. 2022; 13(1):688. PMC: 8813984. DOI: 10.1038/s41467-022-28317-5. View

14.

Corey L, Beyrer C, Cohen M, Michael N, Bedford T, Rolland M . SARS-CoV-2 Variants in Patients with Immunosuppression. N Engl J Med. 2021; 385(6):562-566. PMC: 8494465. DOI: 10.1056/NEJMsb2104756. View

15.

Khan K, Lustig G, Romer C, Reedoy K, Jule Z, Karim F . Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant. Nat Commun. 2023; 14(1):8078. PMC: 10700484. DOI: 10.1038/s41467-023-43703-3. View